Chemical formula: C₁₉H₂₇N₅O₄ Molecular mass: 389.449 g/mol PubChem compound: 2092
Alfuzosin is indicated for:
Population group: men, only adults (18 years old or older)
Treatment of the functional symptoms of benign prostatic hypertrophy (BPH).
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Alfuzosin is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
